[144] Imax Corp SEC Filing

Rhea-AI Filing Summary

Form 144 notice for IMAX (IMAX) reports a proposed sale of 15,072 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $386,560.79 based on 53,782,520 shares outstanding. The approximate sale date is 08/14/2025 on the NYSE. The lots to be sold were largely acquired through restricted stock vesting on 03/07/2023 (multiple grants totaling 8,867 shares) and earlier vesting on 03/07/2021 (233 shares), plus an option exercise scheduled 08/14/2025 for 7,072 shares paid in cash. The filer states no securities of the issuer were sold in the past three months and attests they are not aware of undisclosed material adverse information.

Positive

• Full disclosure of broker, share counts, acquisition dates, and consideration method supports regulatory transparency
• No sales reported in the past three months, indicating this is not part of a pattern of frequent insider selling

Negative

• None.

Insights

Securities Analyst

TL;DR Routine insider sale notice: 15,072 shares proposed for sale, largely from vested restricted stock and an option exercise; not inherently material.

This Form 144 documents a planned disposition of 15,072 IMAX common shares valued at $386,560.79 to be executed via Morgan Stanley Smith Barney on the NYSE on or about 08/14/2025. The holdings originate from standard compensation events: multiple restricted stock vesting dates in 2023 and 2021 and an option exercise dated 08/14/2025. No sales in the prior three months are reported. For investors, this filing is a disclosure of an insider intending to sell equity, which is common after vesting or exercise events and does not by itself indicate company operational issues.

Corporate Governance Expert

TL;DR Disclosure aligns with Rule 144 requirements; filing signals compliance around insider compensation monetization.

The notice appears to comply with regulatory requirements by listing broker details, share counts, acquisition dates and consideration types (services rendered or cash on exercise). The filer attests to absence of undisclosed material adverse information. The mix of vested restricted stock and an option exercise suggests the sale is tied to compensation liquidity rather than an unexpected departure or distress signal. As a governance matter, the clear line-itemization supports transparency for shareholders monitoring insider transactions.

08/14/2025 - 04:16 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15072	386560.79	53782520	08/14/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/07/2023	Restricted stock vesting under a registered plan	Issuer			3478	03/07/2023	Services Rendered
Common	03/07/2023	Restricted stock vesting under a registered plan	Issuer			1090	03/07/2023	Services Rendered
Common	03/07/2021	Restricted stock vesting under a registered plan	Issuer			233	03/07/2021	Services Rendered
Common	08/14/2025	Exercise of options under a registered plan	Issuer			7072	08/14/2025	Cash
Common	03/07/2023	Restricted stock vesting under a registered plan	Issuer			673	03/07/2023	Services Rendered
Common	03/07/2023	Restricted stock vesting under a registered plan	Issuer			359	03/07/2023	Services Rendered
Common	03/07/2023	Restricted stock vesting under a registered plan	Issuer			2167	03/07/2023	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IMAX's Form 144 filed mean for investors?

The filing discloses a proposed sale of 15,072 common shares valued at $386,560.79, to be executed on or about 08/14/2025 through Morgan Stanley Smith Barney.

How were the IMAX shares being sold acquired?

Most shares were acquired via restricted stock vesting on 03/07/2023 and 03/07/2021, and 7,072 shares are from an option exercise dated 08/14/2025 paid in cash.

Which broker is handling the proposed IMAX share sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the filing report recent sales by the same person?

The Form 144 indicates Nothing to Report for securities sold during the past three months.

What assurance does the filer provide about company information?

By signing the notice the filer represents they do not know any material adverse information